ArticleCureus2025
Diagnostic Challenges and Multidisciplinary Management of Invasive Mediastinal Adenocarcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenocarcinoma rarely manifests as a bulky, invasive mediastinal tumor. Even more unusual is when such a tumor, initially diagnosed as another malignancy on biopsy, is later identified as an adenocarcinoma of unknown primary origin. A 46-year-old man with no prior history of malignancy was diagnosed with primary mediastinal seminoma and received chemotherapy before being referred to our hospital. At referral, the tumor had shrunk to half its original size, measuring 7 cm in maximum diameter. Due to its extensive invasion, we performed a combined resection, including the resection and reconstruction of the superior vena cava, achieving complete tumor removal. However, the resected specimen showed extensive necrosis, making it unidentifiable as a tumor. This prompted a reexamination of the pretreatment biopsy, which led to a revised diagnosis of "adenocarcinoma not otherwise specified with clear cell features." Immunohistochemical staining suggested a lung cancer profile, but systemic examination failed to identify the primary site, resulting in a final diagnosis of carcinoma of unknown primary. The cancer recurred 26 months after surgery, and the patient underwent repeated chemotherapy up to the fourth line. He survived for 92 months after surgery before passing away. This case highlights the diagnostic challenges posed by invasive mediastinal adenocarcinoma of unknown primary. It also demonstrates that multidisciplinary treatment - combining induction chemotherapy, curative surgery, and post-recurrence chemotherapy - can enable long-term survival, even in such complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.